Thomas Byron Neff
Keine laufenden Positionen mehr
Karriereverlauf von Thomas Byron Neff
Ehemalige bekannte Positionen von Thomas Byron Neff
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| FIBROGEN, INC. | Vorstandsvorsitzender | 29.09.1993 | 27.08.2019 |
| Vorsitzender | 29.09.1993 | 27.08.2019 | |
| Gründer | 29.09.1993 | 27.08.2019 | |
| Fibrogen China Anemia Holdings Ltd. | Direktor/Vorstandsmitglied | - | 27.08.2019 |
| Claremont McKenna College | Direktor/Vorstandsmitglied | - | 27.08.2019 |
Fibrogen Europe Oy
 Fibrogen Europe Oy BiotechnologyHealth Technology Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland. | Direktor/Vorstandsmitglied | 01.11.1997 | 27.08.2019 |
Kolltan Pharmaceuticals, Inc.
 Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Direktor/Vorstandsmitglied | 01.01.2009 | 01.01.2016 |
Lazard Frères & Co. LLC
 Lazard Frères & Co. LLC Investment ManagersFinance Lazard Freres & Co. LLC provides corporate advisory, capital market, and asset management services. The company was founded on April 13, 1992 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.01.1988 | - |
| Painewebber Group, Inc. | Corporate Officer/Principal | 01.01.1983 | - |
Ausbildung von Thomas Byron Neff
| Claremont McKenna College | Undergraduate Degree |
| The University of Chicago | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 7 |
| Cayman Islands | 2 |
| Finnland | 2 |
Operativ
| Director/Board Member | 4 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 4 |
| Finance | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| FIBROGEN, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Health Technology |
Lazard Frères & Co. LLC
Lazard Frères & Co. LLC Investment ManagersFinance Lazard Freres & Co. LLC provides corporate advisory, capital market, and asset management services. The company was founded on April 13, 1992 and is headquartered in New York, NY. | Finance |
| Painewebber Group, Inc. | Finance |
| Fibrogen China Anemia Holdings Ltd. | |
Fibrogen Europe Oy
Fibrogen Europe Oy BiotechnologyHealth Technology Fibrogen Europe Oy develops and markets recombinant human collagens and gelatins for research purposes. It serves companies in the pharmaceutical, vaccine, medical device, diagnostic, industrial, food, cosmetic, and nutraceutical businesses. The company was founded on May 22, 1996 and is located at Helsinki, Finland. | Health Technology |
- Börse
- Insiders
- Thomas Byron Neff
- Erfahrung
